These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32842267)

  • 1. [Antithrombotic management of patients with atrial fibrillation and coronary artery disease: expert consensus document of Chinese Society of Cardiology].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):552-564. PubMed ID: 32842267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expert answer. Coronary artery patients with atrial fibrillation on anticoagulation treatment may need antithrombotic treatment. What kind is there?].
    Kozan Ö
    Turk Kardiyol Dern Ars; 2012 Jun; 40(4):395. PubMed ID: 23166979
    [No Abstract]   [Full Text] [Related]  

  • 3. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
    Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
    Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.
    Harskamp RE; Alexander JH; Lopes RD
    Eur J Intern Med; 2019 Jul; 65():4-5. PubMed ID: 31128977
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More?
    Gue YX; Gorog DA; Lip GYH
    JAMA Cardiol; 2022 Aug; 7(8):794-795. PubMed ID: 35704350
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting.
    Wrigley BJ; Tapp LD; Shantsila E; Lip GY
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):290-3. PubMed ID: 20693960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombotic strategies for patients with atrial fibrillation and coronary artery disease].
    Ma C; Guo X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):372-3. PubMed ID: 25042912
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].
    Gallet R; Teiger E
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):404-410. PubMed ID: 30342831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotics in atrial fibrillation and coronary disease.
    Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy during and after percutaneous coronary intervention in patients with atrial fibrillation.
    Verheugt FW
    Circulation; 2013 Oct; 128(18):2058-61. PubMed ID: 24166414
    [No Abstract]   [Full Text] [Related]  

  • 15. Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallel.
    Rohla M; Weiss TW; Wojta J; Niessner A; Huber K
    Eur Heart J Cardiovasc Pharmacother; 2015 Jul; 1(3):191-7. PubMed ID: 27533995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
    Paikin JS; Wright DS; Crowther MA; Mehta SR; Eikelboom JW
    Circulation; 2010 May; 121(18):2067-70. PubMed ID: 20458022
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Antithrombotic Therapy in Patients with Coronary Artery Disease or Atrial Fibrillation who Underwent Abdominal Surgical Operations.
    Schizas D; Kariori M; Boudoulas KD; Siasos G; Patelis N; Kalantzis C; Moldovan CM; Vavuranakis M
    Curr Pharm Des; 2018; 24(23):2743-2755. PubMed ID: 29611483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting antithrombotic therapy for patients with atrial fibrillation.
    Tanaka-Esposito C; Chung MK
    Cleve Clin J Med; 2015 Jan; 82(1):49-63. PubMed ID: 25552627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology.
    Fukamachi D; Hirayama A; Miyauchi K; Yasuda S; Ogawa H; Ito H; Daida H
    J Cardiol; 2018 Aug; 72(2):113-119. PubMed ID: 29599096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.